help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism , doi:10.1210/jc.2007-1846
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, K.
Right arrow Articles by Santoro, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, K.
Right arrow Articles by Santoro, N.
Related Collections
Right arrow Pediatric Endocrinology
Right arrow Female Endocrinology
The Journal of Clinical Endocrinology & Metabolism Vol. 93, No. 4 1186-1194
Copyright © 2008 by The Endocrine Society

Onset of Ovulation after Menarche in Girls: A Longitudinal Study

Katie Zhang, Staci Pollack, Ali Ghods, Carrie Dicken, Barbara Isaac, Goli Adel, Gohar Zeitlian and Nanette Santoro

Department of Obstetrics, Gynecology, and Women’s Health, Albert Einstein College of Medicine, Bronx, New York 10461

Address all correspondence and requests for reprints to: Nanette Santoro, M.D., Division of Reproductive Endocrinology, Department of Obstetrics, Gynecology, and Women’s Health, 1300 Morris Park Avenue, Mazer 316, Bronx, New York 10461. E-mail: glicktoro{at}aol.com.


    Abstract
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
Introduction: Hypothalamic-pituitary axis maturity has been believed to be the rate-limiting step in the development of ovulatory menstrual cycles. We hypothesized that, given current nutritional conditions, hypothalamic-pituitary axis maturation would be relatively rapid in menarcheal girls.

Methods: Daily urine and menstrual records were collected for 2 yr each from 10 girls aged 11–13 yr at study entry. Urinary excretion of LH, FSH, estradiol (E1c), and progesterone (Pdg) metabolites was measured using established ELISAs. An objective algorithm detected rises of LH, FSH, E1c, and Pdg consistent with follicular maturation and/or ovulation.

Results: Nine of 10 girls enrolled into the study experienced the onset of menarche prior to or during the 2-yr collection period. LH and FSH surges, as well as small amplitude Pdg increments, were observed prior to menarche. Regular, ovulatory-appearing cycles with LH surges and gradually increasing and more sustained Pdg rises were observed over time after menarche, although duration of Pdg elevations remained shorter than in adult women (8.9 ± 1.0 vs. 12.1 ± 0.8 d, P = 0.043). E1c levels leading to LH/FSH surges were lower in perimenarcheal girls than adult controls, and bleeding episodes did not uniformly correlate with hormone patterns. Progressive increases in FSH and Pdg, but not LH or E1c, were observed in association with menarche.

Conclusion: Mature hormone patterns are established within several months of and even prior to menarche in normal-weight perimenarcheal girls. Factors determining menstrual bleeding in perimenarcheal girls may not be solely dependent on reproductive hormones or the neuroendocrine axis.


    Introduction
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
Amplification of central neural GnRH drive appears to be a key event in pubertal maturation. The rise in serum GnRH observed starting in midchildhood (1) is believed to be due to the convergence of multiple factors, including the appearance of permissive central nervous system regulatory molecules and reactivation of neural pathways and networks (2, 3). Increased amplitude of pulsatile LH secretion first occurs during sleep and gradually proceeds throughout daytime (4). Cyclic, but anovulatory, secretion of gonadotropin at monthly intervals has been hypothesized to occur before the onset of menarche (5). However, the hallmark of full maturation of the hypothalamic-pituitary-ovarian (H-P-O) axis has been considered to be the acquisition of a positive feedback response of the central hypothalamic GnRH pulse generator and pituitary to estradiol (E1c) from the growing ovarian follicle, leading to an LH surge and ovulation (1).

One study that reviewed menstrual records of 250 girls, 100 of whom were studied longitudinally for up to 6 yr (3140 menstrual intervals), indicated that menstrual regularity was established within 2 yr after menarche in the majority (6). Others suggest that up to 5–7 yr of gynecological age are required to establish a reliable ovulatory pattern (7, 8, 9). More recent studies using questionnaires and hormone assessments suggest that regular menstruation is established within 6–12 months of menarche (10, 11). Although menstrual irregularity in adolescent girls is often attributed to an immature H-P-O axis, many adolescents with menstrual abnormalities have an increased risk of continued menstrual abnormality and reproductive disorders (12, 13, 14).

Our working hypothesis is that H-P-O axis maturation is an early event in nutritionally replete, normal-weight adolescent women. To begin to test this hypothesis, we performed a detailed longitudinal pilot study of daily urinary hormone excretion in perimenarcheal girls.


    Subjects and Methods
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
Subjects

Ten healthy volunteers were recruited from the community, using university-wide advertising and oral communications and met the following criteria: 1) age 11–13 yr at study entry, 2) premenarcheal or menarche within 3 months before enrollment, 3) Tanner stage 3 or greater (both breast and pubic hair), 4) height within the fifth to 95th centile of normal for age, 5) body mass index (BMI) for age between the fifth and 95th percentile (15), 6) no personal or family history of hyperandrogenism or polycystic ovary syndrome, and 7) normal prolactin and TSH.

Volunteers meeting these criteria were interviewed by an experienced researcher. Participants were excluded for the following reasons: 1) exercise 4 h/wk or more; 2) one or more first-degree relatives with type 2 diabetes or polycystic ovary syndrome (defined as irregular menstrual cycling and hirsutism or hyperandrogenism); 3) acanthosis nigricans; 4) obesity, defined as BMI for age greater than the 95th percentile [except for participant 2, who reported a BMI of 23 kg/m2 (85%tile) at screening but had a BMI of 28 kg/m2 at examination (>95th percentile, BMI 28 kg/m2)]; 5) history of renal or hepatic disease; and 6) recent voluntary weight loss of 1 lb/week or more. The final sample consisted of six Caucasian, three Hispanic, and one African-American perimenarcheal girls. The study was approved by the institutional review board; all participants and parents or guardians gave informed consent before entry.

Adult controls

Fourteen healthy, regularly cycling women aged 18–38 yr were used as a comparison group. Eleven have been previously reported (16). An additional three control women were added in 2006 along with other quality control steps to assure that the assay has not changed substantially over the past 14 yr. Their results were identical with the original 11. All adult controls had monthly menses at intervals of 25–35 d; did not meet exclusion criteria 1, 5, and 6 above; had normal screening prolactin and TSH; and were free of hirsutism, virilization, or diabetes.

Urine specimen and menstrual calendars collection

Participants collected daily urine samples for a total of 2 yr. These techniques have been reported previously and have been extensively validated (16, 17). Briefly, polypropylene tubes were used with glycerol as a preservative to yield a final concentration of 7% when tubes were filled to a premarked line. Participants were supplied with 90–120 tubes at a time, storage boxes, and written instructions. Each participant collected first-morning voided urine, transferred it to the tube, and froze it within 2 h. Errors or irregularities in collection were recorded on the menstrual calendars.

Participants were asked to record menstrual flow and return monthly calendars. Flow was categorized as either spotting or bleeding on a supplied calendar. Monthly contacts were made to check for any problems or whether menarche had occurred. Specimens and calendars were picked up at least every 3 months. To continue in the study, participants had to provide at least 80% of all possible samples.

Urinary excretion of LH, FSH, E1c metabolites (a mixture of estrone sulfate and estrone glucuronide) and progesterone metabolites (Pdg, pregnanediol) were measured in duplicate using previously established ELISAs using antisera and conjugate tracers provided by Dr. Bill Lasley (University of California, Davis) (18). LH and FSH were measured using a solid-phase, two-site fluoroimmunometric assay (DELFIA; Pharmacia, Gaithersburg, MD) adapted for urine specimens as previously described (19). Urine was assayed neat for gonadotropins and diluted 1:10–11:100 for steroid assays to assure that samples read at or below the ED50 on the standard curve, standardized to creatinine (20), and adjusted for the added glycerol. Intra- and interassay coefficients of variation were: LH: 7.7 and 18.7%; FSH: 9.7 and 16.2%; E1c: 10.3 and 7.9%; and Pdg: 8.2 and 14.5%, respectively.

Data analysis

Data were organized into Excel spreadsheets (Microsoft, Redmond, WA) and inspected for error and completeness. Previously developed algorithms that combed the hormone series for significant rises in LH, FSH, E1c, and Pdg consistent with midcycle surges, follicular maturation and ovulation, respectively, were adapted for use in these samples. Algorithms previously used in SAS (Cary, NC) (21, 22) were rendered functional on SPSS software (version 13.0; SPSS Inc., Chicago, IL). Briefly, to determine ovulation, the data are combed to define the lowest 5-d average of Pdg. An ovulatory rise is defined as a 3-fold increment above this baseline nadir mean that is sustained for at least 3 d (22). Previous validation of this method in midreproductive aged and perimenopausal women confirmed its robustness (21). For LH, FSH, and E1c rises, a 5-d moving average is similarly computed and a rise of at least 3 SD above the moving average for at least 2 d is defined as a surge (for LH and FSH) and a rise (for E1c).

Because these algorithms have not been used before to evaluate hormonal dynamics in pubertal girls, we performed some systematic variations in detection criteria for significant hormone rises to check for robustness of the thresholds. We varied the number of SDs or the number of multiplications of the Pdg nadir (from 2 to 4) required to define a hormone rise or surge. We also varied the number of days (from 4 to 6) of the moving average to which the surge or rise values were compared. A 5-d moving average and a 3 SD threshold was reconfirmed as adequate for detecting surges of LH and FSH and rises in E1c. For Pdg rises, applying the Kassam (22) algorithm without regard to its amplitude resulted in the detection of many rises in Pdg in premenarcheal girls that were of very low amplitude [less than 0.5 µg/mg creatinine (Cr)]. For this reason, we constrained Pdg rises to a minimum amplitude of 1.0 µg/mg Cr. This best represented the visual data and did not change the detection of Pdg rises in the adult controls.

Missing data, problematic for all of the reported detection algorithms, were handled in several different ways. If the missing data resulted from an undetectable assay (11 in participant 3, 16 in participant 4, one in participants 5 and 9, and four in participant 10), it was read by the algorithm as missing and assigned a value of zero (no significant rise). In calculating the moving average, this missing point was disregarded by the algorithm. If more than two consecutive points were missing in calculating a moving average, spurious surges resulted when the mean values for the series were relatively high, compared with the limit of detection; these spurious surges were edited out of the data before analysis. If missing data resulted from samples that were never collected, the series was manually adjusted to make the data points contiguous. Occasionally, clear-cut elevations in Pdg consistent with ovulation were observed immediately after a period of missing values. In these instances, there was no valid prior baseline from which a moving average could be calculated; to correct for the missing data, the hormonal nadir in the data series before the next detectable rise was assigned manually as the baseline to allow for a subject-specific comparison. Then, either a 3-fold or a 1.0 µg/mg or greater Cr rise from the manual baseline was considered to be positive for luteal activity because no SD could be calculated from the interpolated nadir. When the data were reanalyzed assigning undetectable values the same level as the detection limit of the assay, identical results were obtained.

Descriptive characteristics of cycle parameters are expressed as means and interquartile range, SD, or SEM, as indicated. Summary hormonal cycle statistics were compared with adult controls using Wilcoxon rank sum tests. Group mean comparisons were performed using t tests or Wilcoxon testing when data were not normally distributed. Data were standardized to time of menarche for chronological analyses. For these data, repeated measures one-way ANOVA or Kruskal-Wallis testing was used. SPSS 13.0 software and STATA (version 9; STATA Corp., College Station, TX) were used for all analyses. P < 0.05 was considered statistically significant.


    Results
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
Demographic and baseline data are presented in Table 1Go. The reported BMI at telephone screening, used as the entry criterion, differed from the measured BMI in three cases. One girl whose BMI was greater than the 95th centile did not have her data reported with the rest of the group (see below). The other had a BMI of 29 kg/m2, slightly above the 95th centile and one girl had a measured BMI of 14.6 kg/m2, slightly below the fifth centile. Ten girls were recruited. Two had menarche within 3 months before study enrollment; one provided urine for only 3 months, and the other did not return her menstrual calendars for the first 6 months. One girl sustained a head injury 1 month after beginning collection and then developed oligomenorrhea and was subsequently diagnosed with polycystic ovary syndrome. Her data were excluded from analysis. One girl dropped out of the study within 2 months of study enrollment and never initiated urine collection. Of the six remaining girls, all of whom collected urine sample for the full 2 yr, one did not commence menstruation during the collection. Therefore, six of seven possible menstrual calendar series that included or were subsequent to menarche were available for analysis of intermenstrual intervals. Complete data, i.e., full 2-yr urine collections plus informative menstrual calendar data, exist for six girls. Complete hormone data exist for seven girls, and partial hormone data exist for one. Of 4176 total possible samples that could be collected, 725 were missing, for overall compliance of 82.64% (range 76.6–92.2%).


View this table:
[in this window]
[in a new window]

 
TABLE 1. Characteristics of the study cohort

 
Of the seven girls who underwent menarche during the course of their participation (except the one with PCOS), three experienced regular menstrual cycles from 20 to 36 d in length within 6 months of menarche (3–24 months observation), as evidenced by algorithm-detected increases in E1c excretion, LH surges, and Pdg rises. Two more experienced intermenstrual intervals from 20 to 134 d over 7–15 months after menarche. Two girls who had a single menstruation during the study period could not provide intermenstrual interval data.

Hormonal patterns before and after menarche

Figure 1Go shows mean LH, FSH, E1c, and Pdg in 3-month intervals relative to the onset of menarche in eight girls. Although both FSH (P = 0.29) and Pdg (P = 0.33) increased over time, neither was statistically significant. Basal Pdg in premenarcheal girls was 0.71 ± 0.47 (SD), 0.96 ± 0.43 (SD) in postmenarcheal girls and 1.37 ± 0.99 (SD) in adult controls (P = 0.087 for comparison between premenarche and adults). Although means did not differ, the within-participant variance in day-to-day Pdg was significantly greater in postmenarcheal girls, compared with premenarcheal girls (P = 0.028). A trend for an increase in LH, E1 g and Pdg is observed with progressive postmenarcheal cycles (Fig. 2Go).


Figure 1
View larger version (15K):
[in this window]
[in a new window]

 
FIG. 1. Integrated LH, FSH, Pdg, and E1c before and after menarche. Hormones were integrated over identical, 3-month time intervals before and after the first menstrual period (time 0; see text for details). Units of measurement are shown on the y-axis. Not all participants have data available for all time points. (–) Six-month data are an average of five participants, and the remaining three points are each averaged from six participants. Hormonal levels in adult controls (mean ± SEM) are included in each graph for comparison.

 

Figure 2
View larger version (28K):
[in this window]
[in a new window]

 
FIG. 2. Increasing hormone concentrations with progressive cycles containing LH surges. Consecutive cycles are averaged for LH (blue), E1c (red), and Pdg (yellow) and compared with control (rightmost set of bars).

 
Pdg excretion and ovulatory cycles

Pdg peak excretion characteristics for each postmenarcheal participant are summarized in Table 2Go. Small amplitude Pdg increments were observed before menarche (mean 1.33 ± 0.10 µg/mg Cr, range 1.01–1.98 µg/mg Cr), which increased to a mean of 3.88 ± 0.87 (SEM) µg/mg Cr (range 1.07–8.98 µg/mg Cr) within the first 6 months after the onset of menarche. These increments increased slightly 6–12 months after menarche to a mean of 3.95 ± 0.73 (SEM) µg/mg Cr (range 1.85–6.62 µg/mg Cr), and all were lower than adult controls (mean 22.18 ± 5.75 µg/mg Cr, range 5.1–69.3) at all time points (P < 0.000).


View this table:
[in this window]
[in a new window]

 
TABLE 2. General characteristics of hormonal pattern in all observed menstrual episodes

 
LH surges

LH surges were observed before menarche in five girls. Premenarcheal LH surges [21.28 ± 3.90 (SEM) mU/mg Cr] did not differ from adult controls, but postmenarcheal girls had higher surge amplitude than premenarcheal girls [40.16 ± 4.97 (SEM) mU/mg Cr; P = 0.01]. One girl (participant 2; Fig. 3Go) consistently generated LH surges at a magnitude (70.3–102.4 mU/mg Cr) comparable with adult controls within 6 months after menarche. Despite this relatively early appearance of adult-pattern LH surges, no correlation was observed between the magnitude of LH surges and either the magnitude or duration of the subsequent Pdg rise.


Figure 3
View larger version (36K):
[in this window]
[in a new window]

 
FIG. 3. Postmenarcheal participant with adult-type LH surges in response to E1c. In this figure, LH, FSH, and E1c are scaled on the left-sided y-axis and Pdg is scaled to the right-sided y-axis. LH is shown in closed diamonds, FSH in closed squares, Pdg in open diamonds, and E1c in open squares. E1c rises are shown as red stars, and Pdg rises that met criteria for ovulation (see text for details) are shown as orange stars. Note the large LH surge in November and the two large LH surges in December. In Figs. 3–6GoGoGoGo, algorithm-detected LH and FSH surges are represented by blue and green arrows respectively. Menses are indicated by a red arrow.

 
Estrogen metabolites

Baseline E1c excretion before menarche was 11.34 ± 2.66 (SEM) ng/mg Cr in all girls, compared with the early follicular phase mean of 15.02 ± 1.85 (SEM) ng/mg Cr in adult controls (P = 0.363). After menarche, mean E1c increased to 20.05 ± 2.12 (SEM) ng/mg Cr within 3 months and increased slightly to 21.11 ± 4.12 (SEM) ng/mg Cr by 6 months after menarche but remained significantly lower than mean E1c excretion in adult controls [39.71 ± 2.92 (SEM) ng/mg Cr, P = 0.001].

Relationship of hormone patterns to menstrual episodes

Table 2Go indicates the types of patterns that were observed in each of the observed menstruations. Nine of 26 cycles (34.6%) conformed to an adult-type pattern and were preceded by an E1c rise and an LH surge and followed by a Pdg rise (Fig. 4Go). The remaining menstruations had a variety of combinations of these features. Cycles with an LH surge and algorithm-detected E1c but no Pdg rise (Fig. 5Go) and cycles with no detectable change in any of the three hormones (Fig. 6Go) were observed in 11.5% of menstruations recorded.


Figure 4
View larger version (34K):
[in this window]
[in a new window]

 
FIG. 4. Expected menstrual pattern in relation to Pdg excretion in participant with regular, ovulatory cycles. The hormonal pattern is indistinguishable from eumenorrheic adult women. Menses are denoted by red bars under the x-axis. Hormone scales and symbols are identical with those for Fig. 3Go.

 

Figure 5
View larger version (63K):
[in this window]
[in a new window]

 
FIG. 5. In A, participant recorded menstruation after LH surge in the absence of a rise in Pdg but with an increase in E1c. In B, multiple LH and FSH surges can be seen, with one occurring in the absence of an E1c rise and without subsequent menses (June 23, 2004).

 

Figure 6
View larger version (35K):
[in this window]
[in a new window]

 
FIG. 6. Menses (September 8, 2003) in the presence of minimal sex steroids. Note the absence of a rise in E1c or Pdg and no LH or FSH surge. The last increase in E1c was a month before the bleed (August 2003).

 

    Discussion
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
Our pilot study indicates that adult-type menstrual and reproductive hormonal patterns consistent with monthly ovulation occur relatively soon after menarche. Our data are the first to describe the appearance of LH surges before the onset of menarche and in the absence of ovulation. Although our sample size is too small to draw broad-based conclusions, the careful preselection of participants allowed us to observe menarche in all but one participant. The longitudinal, long-term study design also allowed us to observe hormone changes over time in the same individual.

Although menstrual calendars and basal body temperature charts are clinically helpful for establishing the presence of menstrual cycling and ovulation, neither provides sufficient information on the interactions of the three components of the H-P-O axis at the hormonal level. Urinary measurements are useful, noninvasive alternatives to serial blood sampling for assessing hormonal status over long periods of time (16, 17, 18, 21, 23).

Prior epidemiological studies have reported that regular menstruation takes from as few as 2 (10) to as many as 7 yr after menarche (6, 7, 8). Many such studies involved girls who differ from the current U.S. population. Prior studies included few minority women, some of whom attain menarche and undergo pubertal maturation earlier than Caucasians, in part related to increased BMI (24). Weight and BMI were not recorded for some prior studies, some of which involved institutionalized girls (6, 7, 12, 14). It may be that a relatively large proportion of girls in some of these studies (6) were nutritionally marginal, factors that may have led to the findings of relatively slow establishment of regular, ovulatory menstrual cycle patterns. Our sample included girls who were nutritionally adequate to obese, reflective of the current U.S. population (25). The girl with the lowest baseline BMI in our study was the last in the cohort to experience menarche. To the extent that the increase in body fat in adolescent women in the United States over the past century (26) can be viewed as a permissive signal to the hypothalamic-pituitary axis, elimination of undernutrition might be expected to reduce the overall age at menarche. Some but not all (23) studies of age at menarche support this notion.

Our findings are most comparable with a larger study of 112 Caucasian perimenarcheal girls in Pennsylvania, who were followed up every 6 months (10). Maturation of the reproductive axis, as defined by a single urinary progesterone metabolite sample consistent with adult levels, was reportedly achieved within 1 yr after menarche in the majority of the girls. A 6-month frequency of sampling is insufficient to detect monthly ovulations. Our findings of low perimenarcheal Pdg excretion relative to adult women might also have caused an underdetection of ovulation in the Pennsylvania sample. Our results are also consistent with previous findings by Metcalf et al. (9) and Borsos et al. (27), who observed a mature pattern of ovulatory cycles in 23 and 13% women within 1 yr after menarche, respectively. However, these studies are also limited by the use of only weekly urine sampling, which may be inadequate for the detection of some of the brief Pdg rises we observed. These authors considered only luteal phases of greater than 7 d duration to be ovulatory. These more recent cohort studies are in overall agreement with ours in indicating that ovulatory competency is established more rapidly than is widely appreciated. The even more rapid transition to ovulatory competency we observed is likely due to our more intensive sampling paradigm. We were able to demonstrate a progressive increase in the duration of luteal phase, from 2 to 4 d to a length compatible to that of the adult controls (11–12 d), over several months after initial menstruation and an increase in overall Pdg output per luteal phase, indicative of increasing luteal sufficiency over time.

Two girls generated LH surges of an adult magnitude of 26.7 and 21.8 mU/mg Cr with estrogen and progesterone rises, before the onset of menarche. Two other girls also produced LH peaks in response to rises in E1c without a subsequent Pdg rise. These peaks ranged from 21.8 to 47.4 mIU/mg Cr, also consistent with adult, preovulatory LH surges. This discovery would not have been possible without using daily sampling because weekly or semiannual sampling would be highly unlikely to capture events of such short duration. It also indicates that the permissive signals required for acquisition of a positive feedback response are present before hormone patterns are organized into a normal menstrual cycle. Postmenarcheal girls in our study mounted normal-appearing LH surges.

Normal-appearing LH surges and estrogen elevation occurred without significant progesterone metabolite rises in two girls. This finding indicates a possible dyssynchrony between maturation of the H-P-O axis and full ovarian competency and is congruent with observations that irregular menstruation is associated with gynecological age, low BMI, chronic nonspecific lung disease or allergic disease, weight loss, and stress (28). Although most of these factors were excluded in our initial screen, psychosocial stress and allergic diseases were not specifically sought and might have influenced menstrual bleeding patterns. Our observation of small episodic increments in Pdg excretion before menarche supports the working hypothesis of Rosenfield and Barnes (5), that low-amplitude hormonal cycles may occur at early puberty with nighttime levels greater than daytime, although no monthly cyclicity was observed in our participants. These premenarcheal Pdg rises may reflect the normal process of ovarian maturation, which may be an amplification process, in that all the hormonal components are functioning at an adult frequency, but the hormonal signals are dampened and slowly increase to detectable levels.

We also observed menstrual bleeding in girls with low E1c and no evidence of Pdg withdrawal in one instance. This finding suggests that factors determining menstrual bleeding in perimenarcheal girls may not be exclusively dependent on ovarian hormones or may occur in the presence of very small and/or chronic changes in concentrations of E1c and/or progesterone that are undetectable in our urinary sampling paradigm.

The early postmenarcheal cycles we describe herein resemble the infertility syndrome of luteal phase defect (29). However, the onset of normal-appearing LH surges in close temporal association to estrogen elevations before these short Pdg rises in our participants strongly supports the concept that the hypothalamic-pituitary axis is appropriately reactive to the process of folliculogenesis. Whereas a rise in progesterone signifies the development of the corpus luteum after ovulation, a short luteal phase observed after a normal appearing estrogen rise and gonadotropin surge suggests the possibility that the ovary fails to develop an adequate corpus luteum despite normal folliculogenesis. In other words, the neuroendocrine axis may well be comparably matured and similar to adult women within 6 months of menarche, and relative ovarian immaturity accounts for intermittent ovulation. It is also possible that the short Pdg rises we observed close to menarche reflect suboptimal LH surges. However, this seems less likely because the LH dynamics we observed in these girls are well within the normal range (30).

Girls at both extremes of BMI were more likely to have later onset of menarche. This result is partially consistent with previous findings (10) as well as the notion that body weight or body fat is a permissive maturational signal to the hypothalamic-pituitary axis. Our sample size is too small to draw a definitive conclusion, but the possibility that girls with a high BMI are as of yet undiagnosed with ovulatory disorders is supported by our observation that the girl with the highest BMI was ultimately diagnosed with polycystic ovary syndrome.

Our study has several limitations. We were unable to observe directly ovulation events using a definitive technique such as ultrasonography. This would have helped clarify whether the hypothalamus-pituitary and the ovaries mature sequentially, simultaneously, or independently. The sample size also limits generalizability of these findings, which require confirmation in larger samples of young perimenarcheal women. Despite appealing directly to the mothers of the participants to help assure compliance with the protocol, and routine, frequent phone contacts, there is still a small amount of missing data, especially during the summer months when many of the girls went on family vacations. We also experienced difficulty maintaining the menstrual records of two of the participants (lost in the mail). We mitigated this problem by subsequently instructing all participants to save their menstrual calendars for pick-up with urine specimens.

In summary, we have shown that regular ovulatory menstruation patterns can be established within several months of menarche. A time lag may exist between relatively early maturation of the hypothalamic-pituitary and the ovarian response to LH. Factors in addition to reproductive hormones may play a role in determining the onset of menstrual bleeding. Our findings bring new understanding into the physiological events of the maturation of the female reproductive system.


    Footnotes
 
This work was supported by National Institutes of Health Grant K24HD4198 (to N.S.).

Disclosure Statement: The authors have nothing to disclose.

irst Published Online February 5, 2008

Abbreviations: BMI, Body mass index; Cr, creatinine; E1c, estradiol; H-P-O, hypothalamic-pituitary-ovarian; Pdg, progesterone.

Received August 17, 2007.

Accepted January 24, 2008.


    References
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 

  1. Bourguignon JP, Hoyoux C, Reuter A, Franchimont P 1979 Urinary excretion of immunoreactive luteinizing hormone-releasing hormone-like material and gonadotropins at different stages of life. J Clin Endocrinol Metab 48:78–84[Abstract/Free Full Text]
  2. Grumbach M 2002 The neuroendocrinology of human puberty revisited. Horm Res 57(Suppl 2):2–14
  3. Rosenfield RL 2002 Puberty in the female and its disorders. In: Sperling, MA, ed. Pediatric endocrinology. Philadelphia: W. B. Saunders Co.; 455–515
  4. Boyar R, Finkelstein J, Roffwarg H, Kapen S, Weitzman E, Hellman L 1972 Synchronization of augmented luteinizing hormone secretion with sleep during puberty. N Engl J Med 287:582–586[Medline]
  5. Rosenfield R, Barnes, RB 1993 Menstrual disorders in adolescence. Endocrinol Metab Clin North Am 22:491–505[Medline]
  6. Engle E, Shelesnyak M 1934 First menstruation and subsequent menstrual cycles of pubertal girls. Hum Biol 6:431–453
  7. Treloar AE, Boynton RE, Behn BG, Brown BW 1967 Variation of the human menstrual cycle through reproductive life. Int J Fertil 12(1 Pt 2):77–126
  8. Vollman R 1977 The menstrual cycle. Major Probl Obstet Gynecol 7:1–193[Medline]
  9. Metcalf MG, Skidmore DS, Lowry GF, Mackenzie JA 1983 Incidence of ovulation in the years after the menarche. J Endocrinol 97:213–219[Abstract/Free Full Text]
  10. Legro RS, Lin HM, Demers LM, Lloyd T 2000 Rapid maturation of the reproductive axis during perimenarche independent of body composition. J Clin Endocrinol Metab 85:1021–1025[Abstract/Free Full Text]
  11. van Hooff MH, Voorhorst FJ, Kaptein MB, Hirasing RA, Koppenaal C, Schoemaker J 1998 Relationship of the menstrual cycle pattern in 14–17 year old adolescents with gynaecological age, body mass index and historical parameters. Hum Reprod 13:2252–2260[Abstract/Free Full Text]
  12. Southam AL, Richart RM 1966 The prognosis for adolescents with menstrual abnormalities. Am J Obstet Gynecol 94:637–645[Medline]
  13. Apter D, Vihko R 1990 Endocrine determinants of fertility: serum androgen concentrations during follow-up of adolescents into the third decade of life. J Clin Endocrinol Metab 71:970–974[Abstract/Free Full Text]
  14. Gardner J 1983 Adolescent menstrual characteristics as predictors of gynaecological health. Ann Hum Biol 10:31–40[CrossRef][Medline]
  15. 1995 Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser. 854:1–452
  16. Santoro N, Brown JR, Adel T, Skurnick JH 1996 Characterization of reproductive hormonal dynamics in the perimenopause. J Clin Endocrinol Metab 81:1495–1501[Abstract]
  17. Brown J, Skurnick J, Sharma N, Adel T, Santoro N 1993 Frequent intermittent ovarian function in women with premature ovarian failure: a longitudinal study. Endocr J 1:467–478
  18. Lasley BL, Mobed K, Gold EB 1994 The use of urinary hormonal assessments in human studies. Ann NY Acad Sci 709:299–311[Medline]
  19. Saketos M, Sharma N, Adel T, Raghuwanshi M, Santoro N 1994 Time-resolved immunofluorometric assay and specimen storage conditions for measuring urinary gonadotropins. Clin Chem 40:749–753[Abstract/Free Full Text]
  20. Taussky HH 1956 A procedure increasing the specificity of the Jaffe reaction for the determination of creatine and creatinine in urine and plasma. Clin Chim Acta 1:210–224[CrossRef][Medline]
  21. Santoro N, Crawford SL, Allsworth JE, Gold EB, Greendale GA, Korenman S, Lasley BL, McConnell D, McGaffigan P, Midgely R, Schocken M, Sowers M, Weiss G 2003 Assessing menstrual cycles with urinary hormone assays. Am J Physiol 284:E521–E530
  22. Kassam A, Overstreet JW, Snow-Harter C, De Souza MJ, Gold EB, Lasley BL 1996 Identification of anovulation and transient luteal function using a urinary pregnanediol-3-glucuronide ratio algorithm. Environ Health Perspect 104:408–413[Medline]
  23. Demerath EW, Li J, Sun SS, Chumlea WC, Remsberg KE, Czerwinski SA, Towne B, Siervogel RM 2004 Fifty-year trends in serial body mass index during adolescence in girls: the Fels Longitudinal Study. Am J Clin Nutr 80:441–446[Abstract/Free Full Text]
  24. Styne DM 2004 Puberty, obesity and ethnicity. Trends Endocrinol Metab 15:472–478[CrossRef][Medline]
  25. Barlow SE, Dietz WH 1998 Obesity evaluation and treatment: Expert Committee recommendations. The Maternal and Child Health Bureau, Health Resources and Services Administration and the Department of Health and Human Services. Pediatrics 102:E29
  26. Siervogel RM, Demerath EW, Schubert C, Remsberg KE, Chumlea WC, Sun S, Czerwinski SA, Towne B 2003 Puberty and body composition. Horm Res 60(Suppl 1):36–45
  27. Borsos A, Lampe L, Balogh A, Csoknyay J, Ditroi F, Szekely P 1988 Ovarian function after the menarche and hormonal contraception. Int J Gynaecol Obstet 27:249–253[CrossRef][Medline]
  28. van Hooff MH, Voorhorst FJ, Kaptein MB, Hirasing RA, Koppenaal C, Schoemaker J 2000 Insulin, androgen, and gonadotropin concentrations, body mass index, and waist to hip ratio in the first years after menarche in girls with regular menstrual cycles, irregular menstrual cycles, or oligomenorrhea. J Clin Endocrinol Metab 85:1394–1400[Abstract/Free Full Text]
  29. Barbiere R 2004 Female infertility. In: Yen SC, Jaffe RB, eds. Reproductive endocrinology: physiology, pathophysiology, and clinical management. Philadelphia: W. B. Saunders Co.; 633–667
  30. Park SJ, Goldsmith LT, Skurnick JH, Wojtczuk A, Weiss G 2007 Characteristics of the urinary luteinizing hormone surge in young ovulatory women. Fertil Steril 88:684–690[CrossRef][Medline]




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, K.
Right arrow Articles by Santoro, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, K.
Right arrow Articles by Santoro, N.
Related Collections
Right arrow Pediatric Endocrinology
Right arrow Female Endocrinology


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals